Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Anna Masato, Nicoletta Plotegher, Daniela Boassa, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 268

Showing 1-25 of 268 citing articles:

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
Amy D. Proal, Michael B. VanElzakker
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 743
Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders
Yijing Chen, Jinying Xu, Yu Chen
Nutrients (2021) Vol. 13, Iss. 6, pp. 2099-2099
Open Access | Times Cited: 526
The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, et al.
Pharmacological Research (2021) Vol. 172, pp. 105840-105840
Open Access | Times Cited: 496
Molecular Probes, Chemosensors, and Nanosensors for Optical Detection of Biorelevant Molecules and Ions in Aqueous Media and Biofluids
Joana Krämer, Rui Kang, Laura Grimm, et al.
Chemical Reviews (2022) Vol. 122, Iss. 3, pp. 3459-3636
Open Access | Times Cited: 284
Dopamine in Parkinson's disease
Saad Latif, Muhammad Jahangeer, Dure Maknoon Razia, et al.
Clinica Chimica Acta (2021) Vol. 522, pp. 114-126
Closed Access | Times Cited: 220
Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry
Yaping Shao, Tianbai Li, Zheyi Liu, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 149
Impaired dopamine release in Parkinson’s disease
Kaitlyn M. L. Cramb, Dayne Beccano-Kelly, Stephanie J. Cragg, et al.
Brain (2023) Vol. 146, Iss. 8, pp. 3117-3132
Open Access | Times Cited: 88
Role of dopamine in the pathophysiology of Parkinson’s disease
Zhidong Zhou, Ling Yi, Qing Wang, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 75
Depletion of dopamine in Parkinson's disease and relevant therapeutic options: A review of the literature
S Ramesh, Arosh S. Perera Molligoda Arachchige
AIMS neuroscience (2023) Vol. 10, Iss. 3, pp. 200-231
Open Access | Times Cited: 69
Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products
Sasanka Chakrabarti, Marco Bisaglia
Antioxidants (2023) Vol. 12, Iss. 4, pp. 955-955
Open Access | Times Cited: 49
Disease burden of Parkinson's disease in China and its provinces from 1990 to 2021: findings from the global burden of disease study 2021
Tingling Xu, Wenlan Dong, Jinli Liu, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 46, pp. 101078-101078
Open Access | Times Cited: 34
Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications
Paras Mani Giri, Anurag Banerjee, Arpita Ghosal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3995-3995
Open Access | Times Cited: 28
Co Single-Atom Nanozymes for the Simultaneous Electrochemical Detection of Uric Acid and Dopamine in Biofluids
Yiyi Liu, Yong Zhang, Cuncun Wang, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 6, pp. 6273-6283
Closed Access | Times Cited: 20
Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease
E. Maruthi Prasad, Shih‐Ya Hung
Antioxidants (2020) Vol. 9, Iss. 10, pp. 1007-1007
Open Access | Times Cited: 88
The Role of Neurovascular System in Neurodegenerative Diseases
Ajmal Ahmad, Vanisha Patel, Jianfeng Xiao, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 11, pp. 4373-4393
Closed Access | Times Cited: 74
ACSL4 and the lipoxygenases 15/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons
Hind Bouchaoui, Laura Mahoney‐Sanchez, Guillaume Garçon, et al.
Free Radical Biology and Medicine (2022) Vol. 195, pp. 145-157
Open Access | Times Cited: 52
Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease
Yumin Wang, Shuang Wu, Qiang Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 43
Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s disease
D. J. Vidyadhara, Mahalakshmi Somayaji, Nigel Wade, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112231-112231
Open Access | Times Cited: 32
Translational molecular imaging and drug development in Parkinson’s disease
Ahmed Haider, Nehal H. Elghazawy, Alyaa Dawoud, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 29
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease
Anna Masato, Nicoletta Plotegher, Francesca Terrin, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 26
The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases
Sarah E. Davis, Abagail B. Cirincione, Ana Catya Jiménez-Torres, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15340-15340
Open Access | Times Cited: 24
The Misfolding Mystery: α-syn and the Pathogenesis of Parkinson's Disease
Samir Negi, Navneet Khurana, Navneet Duggal
Neurochemistry International (2024) Vol. 177, pp. 105760-105760
Closed Access | Times Cited: 11
The neuroprotective effects of ferulic acid in toxin-induced models of Parkinson's disease: A review
Samira Hassani, Abolghasem Esmaeili
Ageing Research Reviews (2024) Vol. 97, pp. 102299-102299
Closed Access | Times Cited: 10
Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system
Qian Luo, Jiaying Yang, Mei Yang, et al.
Materials Today Bio (2025) Vol. 31, pp. 101457-101457
Open Access | Times Cited: 1
Midbrain circuits of novelty processing
Andrew R. Tapper, Susanna Molas
Neurobiology of Learning and Memory (2020) Vol. 176, pp. 107323-107323
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top